NACDS' opinion piece cites a Drug Channels Institute analysis that DIR fees “have grown faster than most people realize” and reached a record $9.1 billion in 2019.
Medium post extends reach of findings by Kaiser Permanente
The 300,000+ influential readers of Harvard Business Review are seeing pharmacists positioned as part of the solution to high-quality and affordable healthcare.
Read the complete statement provided to The New York Times in January 2020.
Pharmacists strong again in latest Gallup “honesty and ethics” survey
